Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co., Ltd.
  6. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
10/07/2021 10/08/2021 10/11/2021 10/12/2021 10/15/2021 Date
20.75 20.75 21 20.5 20.95 Last
4205529 3851571 2171497 3438791 4826215 Volume
+3.49% 0.00% +1.20% -2.38% +2.20% Change
Estimated financial data (e)
Sales 2021 526 B 81 734 M 81 734 M
Net income 2021 8 231 M 1 280 M 1 280 M
Net Debt 2021 23 842 M 3 706 M 3 706 M
P/E ratio 2021 6,60x
Yield 2021 4,28%
Sales 2022 590 B 91 732 M 91 732 M
Net income 2022 8 731 M 1 357 M 1 357 M
Net Debt 2022 15 142 M 2 354 M 2 354 M
P/E ratio 2022 5,98x
Yield 2022 4,75%
Capitalization 54 091 M 8 405 M 8 409 M
EV / Sales 2021 0,15x
EV / Sales 2022 0,12x
Nbr of Employees 108 370
Free-Float 43,0%
More Financials
Company
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical... 
Sector
Drug Retailers
Calendar
10/22Earnings Release
More about the company
Ratings of Sinopharm Group Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SINOPHARM GROUP CO., LTD.
10/13ASTRAZENECA : Russia says Sputnik Light is 70% effective against Delta variant
RE
10/12PRESS RELEASE : Helsinn and Fosun Pharma sign exclusive license and distribution agreement..
DJ
10/01Singapore Shares End Week Lower; Singtel Slips 1% on Deal to Divest 70% Stake in Austra..
MT
09/30ASIAMEDIC : to Administer Sinopharm COVID-19 Vaccine at Two Clinics; Shares Surge 20%
MT
09/29CHROMADEX : Signs Distribution Agreement of Vitamin Supplement With Sinopharm Xingsha Phar..
MT
09/24CANSINO BIOLOGICS : CanSinoBIO's COVID vaccine, tested at lower dosage, safe for children ..
RE
09/21CLEARBRIDGE HEALTH : Receives Second Second Batch of Sinopharm COVID-19 Vaccines
MT
09/17Sinopharm's COVID booster reverses antibody decline, enhances cell-based responses - st..
RE
09/14BIOALPHA BERHAD : Unit Calls Off COVID-19 Vaccine Import Deal with Zuellig Pharma
MT
09/13EVEREST MEDICINES : to bring Canadian biotech's potential COVID shots to China, other mark..
RE
09/11SINOPHARM : 2021 Interim Report
PU
09/09DUOPHARMA BIOTECH BERHAD : Refutes Reports of Authorizing Bintai Healthcare as Sinopharm's..
MT
09/08BINTAI KINDEN BERHAD : Unit Signs Partnership for Distribution of Sinopharm's COVID-19 Vac..
MT
09/07Singapore Shares Close Higher; Healthway Medical Climbs 6% on Sinopharm Vaccine Deal
MT
09/07HEALTHWAY MEDICAL : to Start Offering Sinopharm COVID-19 Vaccine, Shares Up 6%
MT
More news
News in other languages on SINOPHARM GROUP CO., LTD.
10/14CORONA-BLOG/US-Experten empfehlen Corona-Drittimpfung auch mit Moderna
10/14CORONA-BLOG/Burundi erhält erstmals Corona-Impfstoff
10/11WHO-Beirat empfiehlt dritte Corona-Impfdosis für Immungeschwächte
10/08CORONAVIRUS : le point sur la pandémie dans le monde
10/04COVID : disparità vaccini continuano ad affliggere Paesi poveri
More news
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | 1099 | CNE100000FN7 | MarketScreener
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 17,33 CNY
Average target price 23,10 CNY
Spread / Average Target 33,3%
EPS Revisions
Managers and Directors
Yong Liu President & Executive Director
Xiao Juan Li Chief Financial Officer
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Wu Ping Tao Member-Supervisory Board
Sector and Competitors